Soleus Capital Management, L.P. Insmed Inc Transaction History
Soleus Capital Management, L.P.
- $1.44 Billion
- Q4 2024
A detailed history of Soleus Capital Management, L.P. transactions in Insmed Inc stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 320,272 shares of INSM stock, worth $24.8 Million. This represents 1.54% of its overall portfolio holdings.
Number of Shares
320,272
Previous 30,272
957.98%
Holding current value
$24.8 Million
Previous $2.21 Million
900.95%
% of portfolio
1.54%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding INSM
# of Institutions
498Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.41 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.11 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1.01 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$985 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$552 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...